PHYLLIS VANCE: Open Payments
NPI 1003390980 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$35 in 2 payments from 2 companies in 2025. Trend: 2023 $172 · 2024 $368 · 2025 $35
Food & beverage: $35
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $22 |
| Vanda Pharmaceuticals Inc. | 1 | $13 |
Products named: CAPLYTA, HETLIOZ.
Industry payments across NE — which companies pay providers there.
